BioCentury
ARTICLE | Company News

ACLA , TWTI gene expression deal

October 25, 2001 7:00 AM UTC

Aclara (ACLA) and Third Wave (TWTI) agreed to develop and commercialize multiplexed gene expression products. ACLA will couple its e-Tag sequence labelling technology with TWTI's Invader platform to a...